B Hilvering1,2, S J H Vijverberg1,3, J Jansen4, L Houben1, R C Schweizer1, S Go2, L Xue2, I D Pavord2, J-W J Lammers1, L Koenderman1. 1. Department of Respiratory Medicine, Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands. 2. Nuffield Department of Medicine, Oxford University, Oxford, UK. 3. Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands. 4. Institute for Molecules and Materials, Radboud Universiteit Nijmegen, Nijmegen, The Netherlands.
Abstract
BACKGROUND: The identification of inflammatory asthma phenotypes, using sputum analysis, has proven its value in diagnosis and disease monitoring. However due to technical limitations of sputum analysis, there is a strong need for fast and noninvasive diagnostics. This study included the activation state of eosinophils and neutrophils in peripheral blood to phenotype and monitor asthma. OBJECTIVES: To (i) construct a multivariable model using the activation state of blood granulocytes, (ii) compare its diagnostic value with sputum eosinophilia as gold standard and (iii) validate the model in an independent patient cohort. METHODS: Clinical parameters, activation of blood granulocytes and sputum characteristics were assessed in 115 adult patients with asthma (training cohort/Utrecht) and 34 patients (validation cohort/Oxford). RESULTS: The combination of blood eosinophil count, fractional exhaled nitric oxide, Asthma Control Questionnaire, medication use, nasal polyposis, aspirin sensitivity and neutrophil/eosinophil responsiveness upon stimulation with formyl-methionyl-leucyl phenylalanine was found to identify sputum eosinophilia with 90.5% sensitivity and 91.5% specificity in the training cohort and with 77% sensitivity and 71% specificity in the validation cohort (relatively high percentage on oral corticosteroids [OCS]). CONCLUSIONS: The proposed prediction model identifies eosinophilic asthma without the need for sputum induction. The model forms a noninvasive and externally validated test to assess eosinophilic asthma in patients not on OCS.
BACKGROUND: The identification of inflammatory asthma phenotypes, using sputum analysis, has proven its value in diagnosis and disease monitoring. However due to technical limitations of sputum analysis, there is a strong need for fast and noninvasive diagnostics. This study included the activation state of eosinophils and neutrophils in peripheral blood to phenotype and monitor asthma. OBJECTIVES: To (i) construct a multivariable model using the activation state of blood granulocytes, (ii) compare its diagnostic value with sputum eosinophilia as gold standard and (iii) validate the model in an independent patient cohort. METHODS: Clinical parameters, activation of blood granulocytes and sputum characteristics were assessed in 115 adult patients with asthma (training cohort/Utrecht) and 34 patients (validation cohort/Oxford). RESULTS: The combination of blood eosinophil count, fractional exhaled nitric oxide, Asthma Control Questionnaire, medication use, nasal polyposis, aspirin sensitivity and neutrophil/eosinophil responsiveness upon stimulation with formyl-methionyl-leucyl phenylalanine was found to identify sputum eosinophilia with 90.5% sensitivity and 91.5% specificity in the training cohort and with 77% sensitivity and 71% specificity in the validation cohort (relatively high percentage on oral corticosteroids [OCS]). CONCLUSIONS: The proposed prediction model identifies eosinophilic asthma without the need for sputum induction. The model forms a noninvasive and externally validated test to assess eosinophilic asthma in patients not on OCS.
Authors: Juan Carlos Cardet; Christopher D Codispoti; Tonya S King; Leonard Bacharier; Tara Carr; Mario Castro; Vernon Chinchilli; Ryan Dunn; Fernando Holquing; Linda Engle; Kyle Nelson; Victor E Ortega; Michael Peters; Sima Ramratnam; Jerry A Krishnan; Michael E Wechsler; Elliot Israel Journal: J Allergy Clin Immunol Pract Date: 2018-09-19
Authors: Rita Folcarelli; Selma van Staveren; Roel Bouman; Bart Hilvering; Gerjen H Tinnevelt; Geert Postma; Oscar F van den Brink; Lutgarde M C Buydens; Nienke Vrisekoop; Leo Koenderman; Jeroen J Jansen Journal: Sci Rep Date: 2018-07-19 Impact factor: 4.379
Authors: Dan Mao; Rui Tang; Rui Wu; Hong Hu; Lu Jin Sun; Hong Zhu; Xue Bai; Jing Guo Han Journal: Medicine (Baltimore) Date: 2017-06 Impact factor: 1.889
Authors: Khairul Nizam Mohd Isa; Zailina Hashim; Juliana Jalaludin; Leslie Thian Lung Than; Jamal Hisham Hashim Journal: Int J Environ Res Public Health Date: 2020-07-28 Impact factor: 3.390